168 results
6-K
EX-3.1
GMVDF
G Medical Innovations Holdings Ltd.
18 Dec 23
Report of Foreign Private Issuer
4:39pm
of (to the extent applicable) the Exchange Rules and/or the Exchange, the general nature of the business to be transacted;
(iv)
if the meeting is convened … as to whether any point or matter is of such a nature.
Entitlement to attend and speak
Each Director shall be entitled to attend and speak at any general
6-K
EX-99.2
GMVDF
G Medical Innovations Holdings Ltd.
29 Nov 23
Notice of Extraordinary General Meeting
12:00am
) the Exchange Rules and/or the Exchange, the general nature of the business to be transacted;
(iv) if the meeting is convened to consider a Special Resolution … be final as shall be his determination as to whether any point or matter is of such a nature.
25.6 Entitlement to attend and speak
Each Director shall
D
GMVDF
G Medical Innovations Holdings Ltd.
25 Oct 23
$500.00 k in equity, sold $500.00 k, 1 investor
8:42am
of NSMIA, whether in all instances or due to the nature of the offering that is the subject of this Form D, States cannot
routinely require offering
6-K
EX-99.1
GMVDF
G Medical Innovations Holdings Ltd.
10 Oct 23
Securities Purchase Agreement
4:01pm
in which the nature of the business conducted or property owned by it makes such qualification necessary, except where the failure to be so qualified … that the total liability of the Company under the Transaction Documents for payments in the nature of interest shall not exceed the maximum lawful rate
6-K
EX-99.2
GMVDF
G Medical Innovations Holdings Ltd.
25 Aug 23
Notice of Annual General Meeting
4:20pm
applicable) the Exchange Rules and/or the Exchange, the general nature of the business to be transacted;
(iv)
if the meeting is convened to consider … any point or matter is of such a nature.
Entitlement to attend and speak
Each Director shall be entitled to attend and speak at any general meeting
F-1
nxc9b rz7qp4
27 Jul 23
Registration statement (foreign)
4:47pm
S-8
EX-99.1
5vny 50v4
5 Jul 23
Registration of securities for employees
7:37am
424B4
mkxhmdfvxse17fz9
4 Apr 23
Prospectus supplement with pricing info
12:13pm
6-K
EX-99.1
u1y6on5odf81d8
16 Dec 22
Notice of Extraordinary General Meeting
5:15pm
6-K
EX-99.3
t87vdri69mxi42
18 Nov 22
Report of Foreign Private Issuer
5:25pm
6-K
EX-99.1
96zgaj4z n37y
18 Nov 22
Report of Foreign Private Issuer
12:34pm
6-K
EX-99.1
lll5xh6kc4i0svi
9 Nov 22
Notice of Extraordinary General Meeting
2:05pm
6-K
EX-99.1
q035hhh8qdv8buiiqdh8
31 Oct 22
Notice of Extraordinary General Meeting
6:16pm
6-K
EX-99.1
gbssm
27 Oct 22
Securities Purchase Agreement
4:44pm
424B5
48uui y3yj
19 Sep 22
Prospectus supplement for primary offering
6:49am
6-K
EX-10.1
vp3u1 yzxq5ep7p
19 Sep 22
Report of Foreign Private Issuer
6:04am
POS AM
wf322
13 Jul 22
Prospectus update (post-effective amendment)
1:05pm
POS AM
m5c1v1
13 Jul 22
Prospectus update (post-effective amendment)
1:03pm
F-3
diazp9 9bdrm1dih0
11 Jul 22
Shelf registration (foreign)
4:42pm